ibuprofen - synzeal catalouge/ibuprofen i… · ibuprofen ep impurity f 65322-85-2 c13h18o2 206.3...

1
CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF CAT No CAS No MW : : : : MF Ibuprofen For more information on our products custom synthesis, contact SynZeal today. [email protected] www.synzeal.com SZ-I002001 Rac Ibuprofen 15687-27-1 C13H18O2 206.3 SZ-I002002 Ibuprofen EP Impurity A 66622-47-7 C13H18O2 206.3 SZ-I002003 Ibuprofen EP Impurity B 3585-49-7 C13H17NaO2 228.3 SZ-I002004 Ibuprofen EP Impurity C 59512-17-3 C13H19NO 205.3 SZ-I002005 Ibuprofen EP Impurity D 938-94-3 C10H12O2 164.2 SZ-I002006 Ibuprofen EP Impurity E 38861-78-8 C12H16O 176.3 SZ-I002007 Ibuprofen EP Impurity F 65322-85-2 C13H18O2 206.3 SZ-I002008 Ibuprofen EP Impurity G 1391054-15-1 C26H32O4 408.5 SZ-I002009 Ibuprofen EP Impurity H N/A C24H32O 336.5 SZ-I002010 Ibuprofen EP Impurity I NA C24H34 322.5 SZ-I002011 Ibuprofen EP Impurity J 65813-55-0 C13H16O3 220.3 SZ-I002012 Ibuprofen EP Impurity K 43153-07-7 C10H10O3 178.2 SZ-I002013 Ibuprofen EP Impurity L 53949-53-4 C13H18O3 222.2 SZ-I002014 Ibuprofen EP Impurity M 1262894-13-2 C13H18O3 222.3 SZ-I002015 Ibuprofen EP Impurity N 3585-52-2 C11H14O2 178.2 SZ-I002016 Ibuprofen EP Impurity O 64451-76-9 C13H18O2 206.3 SZ-I002017 Ibuprofen EP Impurity P 93673-13-3 C13H20O 192.3 SZ-I002018 Ibuprofen EP Impurity Q 36039-35-7 C12H18O 178.3 SZ-I002019 Ibuprofen EP Impurity R 102120-87-6 C22H30 294.5 SZ-I002020 4-N-Propylphenyl)Propanoic Acid 3585-47-5 C12H16O2 192.2 SZ-I002021 2-(4-Isobutylphenyl)propanal 51407-46-6 C13H18O 190.3 SZ-I002022 Ibuprofen Impurity 1 75625-99-9 C13H16O2 204.3 SZ-I002023 Ibuprofen Impurity 2 67381-50-4 C10H10O4 194.2 SZ-I002024 Ibuprofen Impurity 3 15935-54-3 C13H16O4 236.3 SZ-I002025 rac 2-Hydroxy Ibuprofen 51146-55-5 C13H18O3 222.28 SZ-I002026 Hydroxy Ibuprofen 53949-54-5 C13H18O3 222.28 SZ-I002027 rac-Ibuprofen Carboxymethyl Ester 1797132-75-2 C15H20O4 264.32 SZ-I002028 (S)-(+)-Ibuprofen Propylene Glycol Ester 95093-58-6 C16H24O3 264.37 SynZeal Research offers all related impurities which certified COA with all characterization data like IR, Mass, HPLC Ibuprofen purity,NMR & TGA report. We also provide CMR, DEPT and detailed structurecharacterization report as perrequirements. related products are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing. Ibuprofen Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID. On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. The S-enantiomer is believed to be the more pharmacologically active enantiomer.

Upload: others

Post on 20-Jul-2020

30 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Ibuprofen - SynZeal Catalouge/Ibuprofen i… · Ibuprofen EP Impurity F 65322-85-2 C13H18O2 206.3 SZ-I002008 Ibuprofen EP Impurity G 1391054-15-1 C26H32O4 408.5 SZ-I002009 Ibuprofen

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

Ibuprofen

For more information on our products custom synthesis, contact SynZeal today.

[email protected] www.synzeal.com

SZ-I002001

Rac Ibuprofen

15687-27-1

C13H18O2

206.3

SZ-I002002

Ibuprofen EP Impurity A

66622-47-7

C13H18O2

206.3

SZ-I002003

Ibuprofen EP Impurity B

3585-49-7

C13H17NaO2

228.3

SZ-I002004

Ibuprofen EP Impurity C

59512-17-3

C13H19NO

205.3

SZ-I002005

Ibuprofen EP Impurity D

938-94-3

C10H12O2

164.2

SZ-I002006

Ibuprofen EP Impurity E

38861-78-8

C12H16O

176.3

SZ-I002007

Ibuprofen EP Impurity F

65322-85-2

C13H18O2

206.3

SZ-I002008

Ibuprofen EP Impurity G

1391054-15-1

C26H32O4

408.5

SZ-I002009

Ibuprofen EP Impurity H

N/A

C24H32O

336.5

SZ-I002010

Ibuprofen EP Impurity I

NA

C24H34

322.5

SZ-I002011

Ibuprofen EP Impurity J

65813-55-0

C13H16O3

220.3

SZ-I002012

Ibuprofen EP Impurity K

43153-07-7

C10H10O3

178.2

SZ-I002013

Ibuprofen EP Impurity L

53949-53-4

C13H18O3

222.2

SZ-I002014

Ibuprofen EP Impurity M

1262894-13-2

C13H18O3

222.3

SZ-I002015

Ibuprofen EP Impurity N

3585-52-2

C11H14O2

178.2

SZ-I002016

Ibuprofen EP Impurity O

64451-76-9

C13H18O2

206.3

SZ-I002017

Ibuprofen EP Impurity P

93673-13-3

C13H20O

192.3

SZ-I002018

Ibuprofen EP Impurity Q

36039-35-7

C12H18O

178.3

SZ-I002019

Ibuprofen EP Impurity R

102120-87-6

C22H30

294.5

SZ-I002020

4-N-Propylphenyl)Propanoic Acid

3585-47-5

C12H16O2

192.2

SZ-I002021

2-(4-Isobutylphenyl)propanal

51407-46-6

C13H18O

190.3

SZ-I002022

Ibuprofen Impurity 1

75625-99-9

C13H16O2

204.3

SZ-I002023

Ibuprofen Impurity 2

67381-50-4

C10H10O4

194.2

SZ-I002024

Ibuprofen Impurity 3

15935-54-3

C13H16O4

236.3

SZ-I002025

rac 2-Hydroxy Ibuprofen

51146-55-5

C13H18O3

222.28

SZ-I002026

Hydroxy Ibuprofen

53949-54-5

C13H18O3

222.28

SZ-I002027

rac-Ibuprofen Carboxymethyl Ester

1797132-75-2

C15H20O4

264.32

SZ-I002028

(S)-(+)-Ibuprofen Propylene Glycol Ester

95093-58-6

C16H24O3

264.37

SynZeal Research offers all related impurities which certified COA with all characterization data like IR, Mass, HPLC Ibuprofen purity,NMR & TGA report. We also provide CMR, DEPT and detailed structurecharacterization report as perrequirements.

related products are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.Ibuprofen

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. The S-enantiomer is believed to be the more pharmacologically active enantiomer.